Gene · 1830
Papers2,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Establishment, characterization, and drug screening of low-passage patient individual non-small cell lung cancer in vitro models including the rare pleomorphic subentity. | Front Oncol | 2023 | 37228492 | PubTator, text mining | PubMed |
| A case of bullous lesions in cutaneous T-cell lymphoma. | JAAD Case Rep | 2023 | 37223111 | PubTator, text mining | PubMed |
| New small molecules in dermatology: for the autoimmunity, inflammation and beyond. | Inflamm Res | 2023 | 37212867 | PubTator, text mining | PubMed |
| Measurement of pesticides in hair samples from pemphigus foliaceus and pemphigus vulgaris patients in Southeastern Brazil. | An Bras Dermatol | 2023 | 37208226 | PubTator, text mining | PubMed |
| Multicentric Castleman disease of hyaline‑vascular variant with paraneoplastic pemphigus results in abnormal lung function: Report of 3 cases. | Exp Ther Med | 2023 | 37206548 | PubTator, text mining | PubMed |
| Immunobullous Transformation of Protracted Psoriasis: A Diagnostic Dilemma. | Cureus | 2023 | 37200636 | PubTator, text mining | PubMed |
| Direct Immunofluorescence of IgG on Formalin-Fixed Paraffin-Embedded Tissue by Heat-Induced Antigen Retrieval as a Sensitive Method for the Diagnosis of Pemphigus. | Clin Cosmet Investig Dermatol | 2023 | 37197669 | PubTator, text mining | PubMed |
| Classification and Antigen Molecules of Autoimmune Bullous Diseases. | Biomolecules | 2023 | 37189450 | PubTator, text mining | PubMed |
| Dupilumab in Inflammatory Skin Diseases: A Systematic Review. | Biomolecules | 2023 | 37189381 | PubTator, text mining | PubMed |
| Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid. | Front Immunol | 2023 | 37180132 | PubTator, text mining | PubMed |
| Mouse models of pemphigus: valuable tools to investigate pathomechanisms and novel therapeutic interventions. | Front Immunol | 2023 | 37180099 | PubTator, text mining | PubMed |
| Anticancer Potential of Sulfonamide Moieties via In-Vitro and In-Silico Approaches: Comparative Investigations for Future Drug Development. | Int J Mol Sci | 2023 | 37175658 | PubTator, text mining | PubMed |
| T Regulatory Cell-Associated Tolerance Induction by High-Dose Immunoglobulins in an HLA-Transgenic Mouse Model of Pemphigus. | Cells | 2023 | 37174740 | PubTator, text mining | PubMed |
| B Cell Profiling in Patients with Pemphigus Vulgaris. | Acta Naturae | 2023 | 37153513 | PubTator, text mining | PubMed |
| Dsg3 epitope-specific signalling in pemphigus. | Front Immunol | 2023 | 37143675 | PubTator, text mining | PubMed |
| Understanding CD4+ T cells in autoimmune bullous diseases. | Front Immunol | 2023 | 37138879 | PubTator, text mining | PubMed |
| Paraneoplastic pemphigus in a patient with a locally invasive, unresectable type B2 thymoma complicated by an intestinal perforation. | JAAD Case Rep | 2023 | 37131866 | PubTator, text mining | PubMed |
| Association of gut microbiome and metabolites with onset and treatment response of patients with pemphigus vulgaris. | Front Immunol | 2023 | 37122759 | PubTator, text mining | PubMed |
| Necrotizing Fasciitis-Severe Complication of Bullous Pemphigoid: A Systematic Review, Risk Factors, and Treatment Challenges. | Medicina (Kaunas) | 2023 | 37109703 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection. | Clin Exp Immunol | 2023 | 37095599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1830/papers?page=16